Víctor Moreno, Antoine Hollebecque, Irene Braña, Andrew Stone, Victoria Moody, Thomas Helleday, Eva Ehrnrooth, Elizabeth Ruth Plummer. "A phase 1/2 first-in-human study of TH9619 in patients with advanced refractory solid tumors (ODIN).." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.tps3165